Skip to content
MedsAcross

Brand names

Influenza a virus a/georgia/12/2022 cvr-167 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/victoria/800/2024 cvr-289 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/singapore/wuh4618/2021 antigen (mdck cell derived, propiolactone inactivated) brand names

1 brands in 1 markets

Influenza a virus a/georgia/12/2022 cvr-167 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/victoria/800/2024 cvr-289 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/singapore/wuh4618/2021 antigen (mdck cell derived, propiolactone inactivated) is sold under 1 brand names in 1 markets in our register data, including Flucelvax. The table shows the market, marketing authorisation holder, strengths and forms for each brand, with the register it comes from.

BrandMarketMarketing authorisation holderStrengths and formsSource
FlucelvaxUnited StatesBamboo US BidCoInjectable suspensionUS FDA NDC directoryChecked 12 November 2026

Brand names and trademarks belong to their owners and are used only to identify products.

Request Influenza a virus a/georgia/12/2022 cvr-167 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/victoria/800/2024 cvr-289 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/singapore/wuh4618/2021 antigen (mdck cell derived, propiolactone inactivated) for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.